±±Ê¦´óϸ°ûÉúÎïѧ£¨ÀúÄêÊÔÌâ×ܽᣩ QAAuFZs
Ò»¡¢ Ãû´Ê½âÊÍ£º T}/|nOu
5
1£® ͬԴºÐ£¨homeobox£©£¨96¡¢99¡¢91£© X}Om)WCr
2£® PCR£¨96£© Uz~B`
3£® ·ºËØ£¨ubquitin£©£¨96£© UA4c4~$S
4£® °é·Ö×Ó£¨chapron£©£¨96£© |?nYs>K
5£® ת¼Òò×Ó£¨trascription factor£©£¨96£© eK5~YM:o
6£® DG£IP3£¨96£© /:ZwGyT;
7£® »ùÒòÇóý£*****ene knock out£©£¨96¡¢00£© +r7hc;+G
8£® ΢¹Ü×éÖ¯ÖÐÐÄ£¨MTOC£©£¨96¡¢01£© {]dG 9
9£® ¶ËÁ£Ã¸£¨telomerase£©£¨96£© R !yh0y}Z
10£® µ°°×·ÖÑ¡£¨protein sorting£©£¨96¡¢99¡¢00£© W?"l6s
11£® Transformation£¨92£© D+BiclJ
12£® TransfectionתȾ£¨92£© %8wBZ~1-
13£® TranscytosisתÒÆ×÷Óã¨92£© %|ClYr
14£® Transductionתµ¼£¨92£© 7r^Cs#b+I
15£® Transdetermination£¨92£© #d*0
)w
16£® Transdifferentiation£¨92£© %@)R
17£® Transgenic animalת»ùÒò¶¯Î92£© $gN\%X/n"1
18£® Rb£1£¨92£© 1zCu1'Wv
19£® P53£¨92¡¢91£© \ 4^zY'
20£® C£jun£¨92£© a6cU<(WDeh
21£® ΢¹Û½áºÏµ°°×MAPS£¨99¡¢91£© g],]l'7H
22£® °ûÄÚÌ壨99£© ~(-1mB,
23£® Cyclin dependent kinase inhibitor(CDKI)(99) ~JNE]mg
24£® G£protein£¨91£© Ook\CK*nKe
25£® Restriction point£¨91£© :3XvHL0rx
26£® Antipost£¨91£© [[]yQ
"
27£® Capping£¨91£© mdyl;e{0
28£® TATAbox£¨91£© Dt> tTU 6
29£® cDNA library£¨90£© i7PS=]TK\
30£® Aritotic apparatus£¨90£© -:pVDxO
31£® ¿çĤÐźŠtransmembrane signal£¨90£© maHz3:
32£® ´ÙÓÐË¿·ÖÁÑÔ mitogen£¨90£© H ?9Bo!
33£® Nuclear lamina£¨90£© jA;b2A]G
34£® ϸ°ûµòÍö£¨apotosis£©£¨00£© -,YI>!
35£® ϸ°ûÍâ»ùÖÊ£¨00¡¢01£© QIU%!9Y
36£® ϸ°û·Ö»¯£¨00£© w'A *EWO
37£® ϸ°ûÐźÅתµ¼£¨signal transduction£©£¨00£© :RukW.MR
38£® ¿Ë¡£¨00£© }~=<7|N.
39£® »ùÒò×飨00£© 5de1r B|
40£® Caspase£¨00£© /m;Bwu
41£® ת¼Òò×Ó£¨00£© -T1R}ew*t
42£® ÅßÌ¥¸Éϸ°û£¨01£© l3u+fE,;_
43£® ¼¤¹â¹²¾Û½¹ÏÔ΢¾µ£¨01£© X
Uh&an$
44£® DNAоƬ£¨01£© X]2Ib'(
¶þ¡¢ ÎÊ´ðÌ⣺ ==?%]ZE8
1£® ÊÔÊöÀÒ°±Ëáµ°°×¼¤Ã¸ÊÜÌåµÄÐźÅͨ·£¨96£© U&:-Vf~&
2£® ÊÔ¾ÙÀý˵Ã÷ÐÅʹϵͳÖÐÓëϸ°ûÔöÖ³Óйصļ¤Ã¸¼°Æ书ÄÜ£¨95£© >T*BEikC
3£® ÊÔ·ÖÎöÐźÅתµ¼£¨transduction£©µÄ¼¸Ìõͨ·µÄ¹²ÐÔÓëÌØÐÔ£¨92£© .#Z'CZO|
4£® µ°°×ÖʵÄÁ×ËữÓëÈ¥Á×ËữÔÚϸ°ûÐźÅϵͳ´«µ¼ÖеÄ×÷Óã¨93¡¢99£© 17c`c.yP
5£® ÊÔÊöÁ×õ¥Ë®½âøC£¨PLC£©µÄ·ÖÀ༰ÔÚϸ°ûÐźÅתµ¼ÖеÄ×÷Óᣣ¨01£© sx;/xIU|
6£® ÊÔÊöϸ°û½ÓÊÜ»¯Ñ§Ðźźóµ÷½Ú»ùÒò±í´ïµÄ;¾¶£¨94£© T,a{mi.hNR
7£® ÊÔÊöϸ°ûÖÜÆÚ¸÷½×¶ÎÖÐCyclins£CdksµÄµ÷¿Ø×÷Óã¨96£© t4d/%b~{:U
8£® ¾ÙÀý˵Ã÷CKIÔÚϸ°ûÔöÖ³µ÷¿ØÖеÄ×÷Óã¨96£© p=eSJ*
9£® ÏêÊöcyclins£cdksϵͳÔÚϸ°ûÖÜÆÚG2/M¼°M/G1¹ý¶ÈÖÐÈçºÎÊܵ½µ÷¿ØµÄ£¿ÒÑÖªÄÇЩ·Ö×Ó¿ÉÄÜÊÇcdksµÄµ×Îï¼°ÆäÔÚÁ×ËữÓëÈ¥Á×Ëữ¹ý³ÌÖжÔϸ°û½á¹¹Ó빦Äܱ仯µÄÓ°Ï죨95£© ;nbEV2Y<
10£® Cdc2ºÍcyclin»ùÒò£¨cdc13£©ÈçºÎµ÷¿Øϸ°ûÖÜÆÚÔËתµÄÏÖ´ú¸ÅÄ92¡¢94£© Gw-{`<CxE
11£® Ϊʲô˵µ°°×ÖÊÁ×Ëữ£È¥Á×ËữºÍ·ºËؽ鵼µÄµ°°×ÖÊË®½â£¨UPP£©µÄ»¥Ïàе÷Íƶ¯Ï¸°ûÖÜÆÚµÄÔËת£¿£¨01£© .Jg<H %%f
12£® ϸ°ûÔöÖ³µ÷¿ØµÄ·Ö×Ó»úÖÆ£¨00£© {wt9/IlG1
13£® ϸ°û¹Ç¼ÜÔÚϸ°ûÔöÖ³ÖÜÆÚÖеÄ×÷Óã¨00£© Y>FLc* h
14£® P34cdc2µÄÐÔÖʼ°Æä×÷Óõ×ÎïÊÇʲô£¿½«ÒýÆðºÎÖÖЧӦ£¿£¨91£© s0vcGh#w
15£® ϸ°ûÓÐË¿·ÖÁÑÖзĴ¸Ìå΢¹ÜµÄ¶¯Á¦Ñ§±ä»¯»úÀí¼°ÆäÓëȾɫÌåÔ˶¯µÄ¹Øϵ£¨95£© DwFvM0O6\
16£® ΢¹ÜµÄ×é×°ÓëÈ¥×é×°ÔÚϸ°ûÓÐË¿·ÖÁѹý³ÌÖеĶ¯Ì¬±ä»¯¼°Æä×÷Óã¨92£© --TH6j"
17£® ϸ°ûÓÐË¿·ÖÁѹý³ÌÖзĴ¸ÌåµÄ×é×°ÓëÈ¥×é×°µÄ¶¯Ì¬±ä»¯¼°Æ书ÄÜ£¨93£© g(s}R ?
18£® ϸ°ûÓÐË¿·ÖÁѺóÆÚȾɫÌå·ÖÀëÇ÷ÏòÁ½¼«µÄ»úÀíÊÇÈçºÎÖ¤Ã÷µÄ£¿£¨90£© s2QgR37s>
19£® ÊÔÊöÖÐÐÄÁ£/¶¯Á£È¥ÔÚϸ°ûÓÐË¿·ÖÁÑÖеÄ×÷Óã¨99£© !=;Evf
20£® KinetochoreÊÇÓÉÄļ¸ÖÖÖ÷Òªµ°°××é³É£¬ÓÃʲô·½·¨Ñо¿Æ䶨λ¡¢·Ö×ÓÁ¿¼°»úÄÜ£¿£¨90£© qkc,93B3
21£® ÊÔ·Ö±ðÐðÊöÈËÀà×ÅË¿Á£ºÍ¶¯Á£µÄ»ù±¾×é³É¼«ÆäÄ¿Ç°ËùÖªµÄ¹¦ÄÜ£¨01£© QjJlVlp
22£® ÊÔÊöϸ°û±à³ÌÐÔËÀÍö£¨programmed cell death£©ºÍϸ°ûµòÍö£¨apoptosis£©µÄÌØÕ÷ºÍÉúÀíѧÒâÒå¼°Æä¿ÉÄܵĻùÒòµ÷¿Ø£¬ÄãÈÏΪÑо¿µÄÖصãÓ¦·ÅÔں䦣¿ÎªÊ²Ã´£¿£¨95£© ]5`A8-Q@
23£® ApoptosisÓëneerosisµÄ¼ì²âÓëÇø±ð£¨99£© K^GvU 0\
24£® ÈçºÎ¼ø±ðϸ°ûµòÍöÓ뻵ËÀ¡£Ï¸°ûµòÍöÑо¿µÄÖØÒªÒâÒåÊÇʲô£¿£¨01£© +|+fDQI
25£® ÊÔÊöunipintin£proteasen proteolytic system£¨99£© *"F*6+}w"
26£® ÒÑÖªÓÐÄÇЩÖ÷ÒªµÄ°©»ùÒòÓëÒÖ°©»ùÒòÓëϸ°ûÖÜÆڵĵ÷¿ØÓйأ¿²¢¾ÙÀý˵Ã÷£¨93£© Ue,eEer
27£® Oncogene¼°Æä²úÎïÓëϸ°ûÔöÖ³µÄ¹Øϵ£¨91£© R*LPwJuv
28£® ¾ÙÀý˵Ã÷oncogene¡¢growth factors¼°ÊÜÌåÖ®¼äµÄÁªÏµ£¨90£© 9S'\&mRl
29£® ÊÔÊöºáÎƼ¡¡¢Ï¸°ûÄÚ´Öϸ˿Á½·Ö×ӵĽṹ¡¢¸÷ÖÖÖ÷Òªµ°°×³É·ÖÔÚ¼¡ÈâÊÕËõÖеÄ×÷Óᣣ¨90£© B}p.fE
30£® ÊÔÊöϸ°ûÖÊÃþÉÏĤµ°°×µÄ¼¸ÖÖÀàÐͼ°Æ书ÄÜ£¨95£© j9RpYz
31£® ÊÔÊöÃâÒßѧ¼¼ÊõÔÚϸ°ûÉúÎïѧÑо¿ÖеÄÓ¦Óã¨92£© j`3IizN2
32£® ͬԴºÐµÄ·¢ÏÖ¼°ÆäÔÚÉúÎïÖеÄÖØÒªÒâÒ壨92£© l<sWM$ez
33£® ÈçÒÑ֪ijһ»ùÒòƬ¶ÎÐòÁкÍÒÑ»ñµÃijһµ¥¿Ë¡¿¹ÌåÓ¦ÓúÎÖÖ¼¼Êõ·Ïߵõ½ËüµÄcDNA¿Ë¡£¨94£© (lYC2i_b#
34£® ¾ÙÀý˵Ã÷ÃâÒßÓ«¹âFISH¡¢ÃâÒߵ羵ÖîÏî¼¼ÊõµÄ»ù±¾ÔÀí¼°ÆäÔÚϸ°ûÉúÎïѧÑо¿Öеĸ÷½â¾öʲôÎÊÌ⣨94£© @.`H
vS
35£® ÄãµÄ˶ʿÂÛÎÄÌá³öÁËʲôÎÊÌ⣿ÈçºÎ½â¾öµÄ£¿½áÂÛÊÇʲô£¿£¨96¡¢94¡¢00£©